
Every year a company rewrites its risk factors. “We may be unable to retain our largest customers” quietly becomes “we have been unable to.” Almost nobody reads both versions. Name a ticker. RiskDelta pulls the last two SEC filings, isolates Item 1A from each, and reports what was added, what was removed, and where hedged language hardened into fact — with the filing’s own words as evidence. Disclosure analysis only. No recommendations.

Daily HTML briefing of what actually moved on Polymarket in the last 24 hours: the biggest odds shifts (each with a one-line news-researched explanation of why), volume surges where money is flowing, multi-day trends, new markets gaining traction, and contested markets resolving soon. Scans 300+ active markets, filters out the noise, and delivers one consistent 5-minute morning read. Data briefing only — no trade calls, no predictions. Not financial advice.

Say “dashboard” and see this week’s 8-K Item 3.01 listing notices — exchange, rule cited, notice type, cure period — each row linked to EDGAR.

Consistent two-horizon stock analysis — verified numbers, explicit bear case, no hype

Turn raw 30-day cross-platform chatter into actionable market truth. Deep sentiment, competitor tracking, and trend intelligence across Reddit, Hacker News, Polymarket, and TikTok.

Insider Radar reads SEC Form 4 filings every morning and surfaces the one signal that matters: insiders buying their own stock on the open market. It filters out grants and option exercises, flags clusters where multiple insiders buy the same ticker, and ranks each by role (CEO/CFO/director/10% owner) and dollar size. Includes notable discretionary insider selling. Not investment advice.

Daily scan of ~5,700 US stocks for three publicly-known Qullamaggie chart patterns — Episodic Pivot, Breakout, Parabolic. Interactive bilingual dashboards, per-ticker pattern characteristics, earnings-catalyst checks and a market-regime gauge. Reports objective pattern data and historical statistics only — no entry/stop/target, no position sizing, no "best" pick. Screening & education, not investment advice.
